Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Corporate layoffs stories

Nov 13, 2026

AstraZeneca cuts 600 US sales jobs in respiratory and immunology

AstraZeneca has eliminated approximately 600 positions from its US respiratory and immunology commercial teams as part of a three-year cost-savings initiative.

Nov 13, 2026·2 sources
00
Nov 3, 2026

Ultragenyx to cut 20% of workforce after Wilson disease gene therapy failure

Ultragenyx Therapeutics announced plans to lay off approximately 20% of its employees and discontinue development of its Wilson disease gene therapy GTX-102 following a major setback in Angelman syndrome trials.

Nov 3, 2026·2 sources
00
Oct 27, 2026

Artiva discontinues cell therapy after two patient deaths, cuts workforce by 94%

Artiva Biotherapeutics halted development of its experimental cell therapy for autoimmune conditions following two patient deaths in clinical trials and announced massive workforce reductions.

Oct 27, 2026·4 sources
00
Aug 24, 2026

Bristol Myers ends blood cancer drug partnership with Cellares

Bristol Myers Squibb terminated its partnership with cell therapy startup Cellares to expand manufacturing of its personalized blood cancer therapy, prompting Cellares to lay off 100 employees.

Aug 24, 2026·2 sources
00
Jul 18, 2026

Samsung Electronics America to reduce workforce by 739 in New Jersey

Samsung Electronics America is cutting 739 jobs in Englewood Cliffs, New Jersey, according to a Worker Adjustment and Retraining Notification (WARN) notice reviewed by Reuters.

Jul 18, 2026·1 source
00
Jun 26, 2026

Biogen Scales Back Apellis Programs and Cuts Research Roles Following $5.6 Billion Acquisition

Biogen has paused or discontinued funding for most of Apellis Pharmaceuticals' research programs and is trimming research positions as it integrates the rare-disease drugmaker it acquired for $5.6 billion.

Jun 26, 2026·1 source
00

Top claims

  • ▪GSK Plc plans to relocate its research and development headquarters to Cambridge, United Kingdom, near AstraZeneca's global headquarters
  • ▪AstraZeneca pledged to invest $50 billion in the United States to expand manufacturing operations and generate tens of thousands of jobs
  • ▪Rival drugmaker GSK Plc is reducing costs to fund pipeline development before patent protection expires on an HIV drug before 2030

Subtopics

Corporate restructuring3Pharmaceutical Industry3Pharma2Angelman syndrome1Asthma1Autoimmune disease treatments1Biotech innovation1Biotech startup1Biotechnology1Cancer & Oncology1Cancer Treatment & Therapies1CAR T-cell therapy1Clinical trials1COPD1Corporate strategy1Drug Approval and Clinical Trials1Drug Policy, Pricing & Approval1Drug safety1Eli Lilly1FDA regulation1Gene therapy1Genetic diseases1Hematology & Blood Cancers1Labor displacement1

Related timelines

Congress

110 stories

Crypto hacks

100 stories

Iran War

209 stories

Payments

118 stories

Russia-Ukraine war

136 stories